Replies to post #18749 on Momenta Pharmaceuticals, Inc. (MNTA)

[MadCityCyclone]

Because CW has never had a deadline that he couldn't miss.

As easy as everyone makes it sound, why in Feb did CW say trials (in human, I can't see why the FDA would want this crap with such a miraculous drug) were starting in the first half and then months later move the trials to the second half of 18'?

[funindasun]

Can mice really self-infuse themselves?

Nah! I wouldn't teach them how to do it either, they can't pay for the cost of infusion. Let them take regular ivig in one of Baxter's clinics.

As easy as everyone makes it sound, why in Feb did CW say trials (in human, I can't see why the FDA would want this crap with such a miraculous drug) were starting in the first half and then months later move the trials to the second half of 18'?

February 21 2018 Earnings call
CW...

Lastly, I'll comment on M254, our hyper-sialylated IVIg program designed as a potential high-potency version of IVIg. In late 2017 we initiated an IND-enabling toxicology study and we were targeting the initiation of a Phase I clinical trial in the second half of 2018. Our goal for M254 is to initiate a clinical trial designed for a rapid proof of concept for this drug which we believe has the potential to have a major impact in terms of enhanced potency, convenience and safety over what is currently a high burden of treatment with IVIg.